To Access the Effects of Mucositis in Adults With Dental Implants

Inclusion criteria

• Male and female subjects, ages 30-70.
• Availability for the six-month duration of the clinical research study.
• Good general health.
• Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants.
• Minimum of 5 remaining teeth and a minimum of 2 implants.
• Initial evaluation of the gingival and peri-implant mucosal tissues by determining full mouth bleeding on probing.
• Initial plaque evaluation by determining full mouth presence/absence of plaque.
• Signed Informed Consent Form.

Exclusion criteria

• Tumor(s) of the soft or hard tissues of the oral cavity.
• Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone).
• Carious lesions requiring immediate restorative treatment.
• Uncontrolled Diabetes
• Use of antibiotics any time during the one month prior to entry into the study.
• Untreated peri-implantitis.
• Participation in any other clinical research study or test panel within the three months prior to entry into the study.
• Pregnant women or women who are breast feeding.
• History of allergies to personal care/consumer products or their ingredients.
• Medical condition which prohibits not eating/drinking for up to 2 hours.
• Current alcohol or drug abuse.
• Systemic or local disease conditions that would compromise post-operative healing.
• Regular use of anti-inflammatory drugs.